References
- Webster A., Lever A. Intramuscular versus intravenous administration of immunoglobulin preparations. Clinical uses of Intravenous Immunoglobulin, A. Morell, U. Nydegger. Academic Press Inc., London 1986; 67–73
- Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukaemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukaemia. N. Engl. J. Med 1988; 319: 902–7
- Preest D., Schedel I. Humoral immunodeficiency in multiple myeloma. Intravenous Immunoglobulins. The Medicine Publishing Foundation, Oxford 1988; 49–56
- Sullivan K., Kopecky K., Jocom J. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N. Engl. J. Med 1990; 323: 705–12
- Peterson F., Bowden R., Thornquist M. The effect of prophylactic intravenous immune globulin on the incidence of septicaemia in marrow transplant recipients. Bone Marrow Transplantation 1987; 2: 141–148
- Schmidt R., Hartlapp J., Niese D. Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lung. Infection 1984; 12: 167–170
- Newland A. C., Veys P. A. Intravenous immunoglobulin. Immunotherapy of disease, J. Hamblin. Kluwer Academic Publishers. 1989; 21–42
- Hill H. R., Bathras J. M. Protective and opsonic activities of a native pH4.25 intravenous immunoglobulin G preparation against common bacterial pathogens. Reviews of Infectious disease 1986; 8: 396–400
- Pennington J. E. Recent experience with Pseudomonas aeruginosa immune globulin for the treatment of experimental pneumonia. Journal of Hospital Infection 1988; 12: 55–60
- Mancilla J., Castellanos M. C., Santos J. Opsonic activity and protective efficacy of an intravenous immunoglobulin against Klebsiella pneumonia. Interscience conference on Antimicrobial agents and chemotherapy. New York, Abst. 544, Am. Soc. for Microbiol, Washington D.C. 1987
- Stephan W., Dichtelmuller H., Schedel I. Properties and efficacy of a human immunoglobulin M preparation for intravenous administration. Drug res 1985; 35: 933–936
- Dichtelmuller H., Stephan W. Studies in the efficacy of immunoglobulin M enriched intravenous immunoglobulin against bacterial infection and neutralisation of bacterial toxins. Drug res 1987; 37: 1273–1276
- Graham-Pole J., Camitta B., Casper J. Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: a pediatric oncology group study. Bone Marrow Transplantation 1988; 3: 559–566
- Cross A., Alving B., Sadoff J. Intravenous immune globulin: A cautionary note. The Lancet 1984; ii: 912